PRECISIONheor, LLC
Industry / private company
Location:
New York,
United States (USA) (US)
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab for treatment of high-risk, early-stage triple-negative breast cancer: A network meta-analysis (2022)
Cortes J, Haiderali A, Huang M, Pan W, Fox GE, Park J, Frederickson AM, et al.
Conference contribution
Economic and Humanistic Burden of Triple-Negative Breast Cancer: A Systematic Literature Review (2022)
Huang M, Haiderali A, Fox GE, Frederickson A, Cortes J, Fasching P, O'Shaughnessy J
Journal article, Review article